|
DCAF16 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.15099999999468E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.65489999999613E-05 |
| Normal-vs-Stage2 |
2.551000E-01 |
| Normal-vs-Stage3 |
2.51699999997967E-06 |
| Normal-vs-Stage4 |
6.875800E-01 |
| Stage1-vs-Stage2 |
2.649200E-01 |
| Stage1-vs-Stage3 |
4.258400E-01 |
| Stage1-vs-Stage4 |
1.029040E-01 |
| Stage2-vs-Stage3 |
1.596010E-01 |
| Stage2-vs-Stage4 |
2.930000E-01 |
| Stage3-vs-Stage4 |
7.611800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.03019999999166E-05 |
| Normal-vs-AfricanAmerican |
4.595100E-03 |
| Normal-vs-Asian |
2.437500E-03 |
| Caucasian-vs-AfricanAmerican |
4.344000E-01 |
| Caucasian-vs-Asian |
4.606600E-01 |
| AfricanAmerican-vs-Asian |
3.572800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.55409999999823E-06 |
| Normal-vs-Female |
1.032810E-01 |
| Male-vs-Female |
2.638700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.322360E-02 |
| Normal-vs-Extreme_Weight |
1.41959999999663E-06 |
| Normal-vs-Obese |
3.703400E-03 |
| Normal-vs-Extreme_Obese |
2.986400E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.457190E-01 |
| Normal_Weight-vs-Obese |
9.439200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.408970E-01 |
| Extreme_Weight-vs-Obese |
7.269500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.947800E-01 |
| Obese-vs-Extreme_Obese |
2.287000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.093400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.032700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.25179999999059E-06 |
| Normal-vs-Age(81-100Yrs) |
5.69349999999247E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.373850E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.364000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.658200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.544100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.174750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.954800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.70049999998123E-06 |
| Normal-VS-Type2 PRCC |
5.61679999955267E-07 |
| Normal-VS-KIRP CIMP |
1.689600E-01 |
| Normal-VS-Unclassified PRCC |
1.835600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.168000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.9689000000378E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
9.142300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.44149999999443E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
3.081800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.998600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.62780000274077E-08 |
| Normal-vs-N1 |
4.866600E-01 |
| Normal-vs-N2 |
6.239000E-01 |
| N0-vs-N1 |
3.496100E-02 |
| N0-vs-N2 |
5.906800E-01 |
| N1-vs-N2 |
7.912000E-01 |
|
|
